References
- Beten D. B., Gelbcke M., Diallo B., Moes A. J. Interaction between dipyridamole and Eudragit S. International Journal of Pharmaceutics 1992; 88: 31–37
- Beten D. B., Moes A. J. Controlled-release coevaporates of dipyridamole prepared with acrylic polymers. International Journal of Pharmaceutics 1994; 103: 243–251
- Deasy P. B. Microencapsulation and Related Drug Processes. Dekker, New York 1984; 145–153
- Fassio G., Albizzati M. G., Bassi S., Frattola L. An investigation of the effect on platelet function of acetylsalicylic acid, dipyridamole and the two drugs in combination in patients with transient attacks of ischaemia. Journal of International Medical Research 1979; 7: 492–501
- Hasegawa A., Kawamura R., Nakagawa H., Sugimoto I. Application of solid dispersions with enteric coating agents to overcome some pharmaceutical problems. Chemical and Pharmaceutical Bulletin 1986; 34: 2183–2190
- Lehmann C. R., Loche K., Shafler P. J., Pierson W. P. Persantin bioavailability problems. Clinical Pharmacy 1984; 3: 14–15
- Mellinger T. J., Bohorfoush J. G. Pathways and tissue distribution of dipyridamole (Persantin). Archives of International Pharmacodynamics 1965; 156: 380–388
- Nielsen-Kudsk F., Pedersen A. K. Pharmacokinetics of dipyridamole. Acta Pharmacology and Toxicology 1979; 44: 391–399
- Rajah S. M., Penny A. F., Cow M. J., Pepper M. D., Watson D. A. The interaction of varying doses of dipyridamole and acetylsalicylic acid on the inhibition of platelet functions and their effect on the bleeding time. British Journal of Clinical Pharmacology 1979; 8: 483–489
- Segall G. M., Davis M. J. Variability of serum drug level following single oral dose of dipyridamole. Journal of Nuclear Medicine 1988; 29: 1662–1667
- Terhaag B., Donath F., Le petit G., Feller K. The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro-in vivo comparison. International Journal of Clinical Pharmacology, Therapy and Toxicology 1986; 24: 298–302
- Thiessen J. J. Aspirin:plasma concentration and effects. Thrombosis Research 1982; IV: 163–170, (Supplement)
- Williams C., Mayer P. R., Kildsig D. O. Dissolution profiles of two tablet formulations of dipyridamole and their bioavailability. International Journal of Pharmaceutical Technology and Product Manufacture 1983; 4: 74–76